Insider Title Company Date Price Return Shares Value
Radhakrishnan Karthik Chief Financial Officer Monopar Therapeutics (MNPR) 2024-10-28 $16.25 0.0% 1,550 $25,188
Return Profit / (loss) Cost
Total 0.0% $0 $25,188